Early Phase

The Life Sciences Summit is an early stage investor and business development conference that highlights innovation. The objective of the event is to connect emerging biotech companies and academic innovators with the capital and strategic partners they will need to move new discoveries through clinical development. The two-day program features corporate presentations by promising young companies with transformative science that targets unmet medical needs. It also features informative plenary sessions, business workshops, and therapeutic sessions.

Please join us for our quarterly Life Sciences Investor Forum. This day-long event will feature companies from the life sciences industry. More information will be available closer to the event date.

BioTrinity is OBN’s flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. Including a mix of early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers.

Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.

Empowering innovation, accelerating investment and facilitating knowledge and networking to shape the future of healthcare Where innovators, investors and senior life science dealmakers in the LSX community connect, learn and partner

This prestigious conference is an exclusive global partnering forum that brings together nearly 600 senior executives and CEOs, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies from over 20 countries. This conference features panel discussions and keynote presentations, one-on-one partnering meetings, small company presentations, presentations from leading research institutions, and endless networking opportunities

BioCapital Europe is Europe’s premier life sciences investment conference, offering VCs and Institutional Investors unique and timely access to around 40 exciting biotech, medtech and diagnostics companies from the Benelux and Europe.

[From 2021] Conditions permitting, we plan to host the conference both in-person in London and virtually. This year marks the 12th anniversary of the largest healthcare-dedicated conference in Europe. In 2020, we hosted over 550 participating companies, 3,000 attendees, and 6,500 business-to-business and investor meetings. Our conference will again feature leading public and private companies from the pharmaceuticals, biotechnology, medical technology, and healthcare services sectors from the Americas, Europe, Middle East, Africa, Asia, and Australia.

Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs – join the discussion in Dublin, or attend from home via a digital pass. Plus take advantage of two bonus days of digital 1×1 meetings. Additional details to be released shortly, check back for updates.

[From 2021] The BIO Investor Forum Digital is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and BIO One-on-One Partnering™ meetings.